Vitamin D, obesity and risk of diabetes

Abstract

Vitamin D deficiency is on the increase all over the world. The clinical role of vitamin D in calcium and bone metabolism is well known, but lower levels of the vitamin are also linked to obesity and an increased risk of developing cardiovascular disease, type 2 diabetes, and cancer. The molecular mechanisms of these associations are only partially understood, but it is known that vitamin D stimulates lipolysis and inhibits adipogenesis in human adipocytes, and lower vitamin D may induce body fat accumulation. Vitamin D receptors are expressed in pancreatic beta cells and skeletal muscle cells, and their activation results in increased insulin release and responsiveness to insulin for glucose transport. Vitamin D has recently been found to have potent antiproliferative, prodifferentiative, and immunomodulatory effects in many tissues. Vitamin D deficiency is often missed clinically even though its measurement is a simple laboratory test and its treatment is inexpensive and usually well tolerated. Nevertheless, physicians are not sufficiently informed about the effects of vitamin D other than those on the skeletal metabolism, and they rarely ask for plasma vitamin D measurement. The purpose of this review is to examine the association between vitamin D deficiency, obesity, and the risk of type 2 diabetes.


Autore Pugliese

Tutti gli autori

  • DE PERGOLA G.

Titolo volume/Rivista

Non Disponibile


Anno di pubblicazione

2012

ISSN

1828-6232

ISBN

Non Disponibile


Numero di citazioni Wos

Nessuna citazione

Ultimo Aggiornamento Citazioni

Non Disponibile


Numero di citazioni Scopus

Non Disponibile

Ultimo Aggiornamento Citazioni

Non Disponibile


Settori ERC

Non Disponibile

Codici ASJC

Non Disponibile